Two Directors at Deckers Outdoor Corp bought/sold after exercising options 2,125 shares at between 109.076USD and 109.764USD. The significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by...
A director at Edwards Lifesciences Corp sold 17,066 shares at 77.220USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
We consider the merged platform Kadimastem (KDST.TA) + NLS Pharmaceutics (NLSP:NasdaqCM). We provide an investment case analysis and a selection of merged metrics prior to any synergies. The merger creates a cross-platform pre-revenue biotech with lead programs including a proprietary stem-differentiation platform capable of delivering scalable therapies for replacing lost or damaged cells; IsletRx could revolutionize insulin production for Type 1 diabetes (T1D) patients; AstroRx® targets neurod...
A director at Nike Inc gave away/sold after exercising options/sold 164,271 shares at 0.000USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's director...
Two Directors at Crocs Inc sold 12,183 shares at between 109.470USD and 115.895USD. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
A director at Penumbra Inc sold 2,000 shares at 299.010USD and the significance rating of the trade was 64/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Weyco Reports First Quarter Sales and Earnings MILWAUKEE, May 06, 2025 (GLOBE NEWSWIRE) -- Weyco Group, Inc. (NASDAQ: WEYS) (“we,” “our,” “us” and the “Company”) today announced financial results for the quarter ended March 31, 2025. First Quarter 2025 Overview Net sales: $68.0 million (down 5% compared to $71.6 million in Q1 2024)Gross earnings: 44.6% of net sales (compared to 44.7% of net sales in Q1 2024)Earnings from operations: $7.0 million (down 15% compared to $8.3 million in Q1 2024)Net earnings: $5.5 million (down 17% compared to $6.7 million in Q1 2024)Diluted earnings...
WEYCO Group, Inc. First Quarter 2025 Earnings Conference Call Milwaukee, WI, April 09, 2025 (GLOBE NEWSWIRE) -- WEYCO Group, Inc. (NASDAQ: WEYS), a global marketer of footwear, plans to announce first quarter 2025 financial results after the close on Tuesday, May 6, 2025. Additionally, Thomas W. Florsheim, Jr., Chairman and CEO, will host a conference call on Wednesday, May 7, 2025, at 11:00 a.m. Eastern Time to discuss the financial results in more detail. To participate in the call, please dial 1-888-596-4144 or 1-646-968-2525, using passcode 6441034# at least fifteen minutes before t...
BEAVERTON, Ore.--(BUSINESS WIRE)-- NIKE, Inc. (NYSE:NKE) today reported fiscal 2025 financial results for its third quarter ended February 28, 2025. Third quarter revenues were $11.3 billion, down 9 percent on a reported basis compared to the prior year and down 7 percent on a currency-neutral basis* NIKE Direct revenues were $4.7 billion, down 12 percent on a reported basis and down 10 percent on a currency-neutral basis Wholesale revenues were $6.2 billion, down 7 percent on a reported basis and down 4 percent on a currency-neutral basis Gross margin decreased 330 basis points to 41....
Diabetes mellitus, Type 1 (T1D) and Type 2 (T2D, 85-90% of cases), is a USD ~75bn global therapy market. Global economic costs of diabetes may exceed USD1 trn today and USD 450bn in the US, suggesting a pressing global health challenge. Diabetes is a chronic metabolic disorder characterized by high blood sugar levels. In 2024, consensus global estimates suggested there were ~800m adult diabetes sufferers. In 2021, according to the IDF there >530m sufferers globally. For 2027E we modestly forecas...
A director at Skechers USA Inc sold 10,994 shares at 56.630USD and the significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
Weyco Reports Fourth Quarter and Full Year 2024 Results MILWAUKEE, March 04, 2025 (GLOBE NEWSWIRE) -- Weyco Group, Inc. (NASDAQ: WEYS) (“we,” “our,” “us” and the “Company”) today announced financial results for the quarter and year ended December 31, 2024. Fourth Quarter 2024 Overview Net sales: $80.5 million (flat with Q4 2023)Gross earnings: 47.9% of net sales (down compared to 50.3% of net sales in Q4 2023)Earnings from operations: $11.5 million (flat with Q4 2023)Net earnings: $10.0 million (up 17% compared to $8.5 million in Q4 2023)Diluted earnings per share: $1.04 (up from $0.90 ...
A director at Wolverine World Wide Inc bought 20,000 shares at 14.770USD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.